Friday, November 6, 2020 | 6:00 PM EST
Supported by Boehringer Ingelheim Pharmaceuticals, Inc.
Primary Session Topic:
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Upon completion of this session, participants should be able to:
- Provide an overview on common autoimmune-associated ILDs and the impact of these ILDs on patients
- Improve the identification of patients with potential autoimmune-associated ILDs in order to support a timely and accurate diagnosis
- Review case examples with HRCT images of autoimmune-associated ILDs to enhance diagnosis and effective care for patients
This program is developed and offered by Boehringer Ingelheim. This is not an official program of the American College of Rheumatology.
Chase S. Correia, MD
Felipe Martinez, MD